ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.120
-0.070 (-2.19%)
Aug 15, 2025, 10:28 AM - Market open
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $351.00 million as of August 15, 2025. Its market cap has increased by 5.12% in one year.
Market Cap
351.00M
Enterprise Value
545.08M
1-Year Change
5.12%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $351.00M, a decrease of -82.82%. That is a compound annual growth rate of -28.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 358.87M | 86.51% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |